tradingkey.logo

Co-Diagnostics Inc

CODX
2.360USD
0.0000.00%
收盘 02/06, 16:00美东报价延迟15分钟
113.62M总市值
亏损市盈率 TTM

Co-Diagnostics Inc

2.360
0.0000.00%

关于 Co-Diagnostics Inc 公司

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc简介

公司代码CODX
公司名称Co-Diagnostics Inc
上市日期Jul 12, 2017
CEOEgan (Dwight H)
员工数量132
证券类型Ordinary Share
年结日Jul 12
公司地址2401 S. Foothill Dr. Suite D
城市SALT LAKE CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84109
电话18014381036
网址https://codiagnostics.com/
公司代码CODX
上市日期Jul 12, 2017
CEOEgan (Dwight H)

Co-Diagnostics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.97K
+1917.00%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.89K
+1917.00%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.97K
+1917.00%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.89K
+1917.00%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
136.74K
94.06%
Rest of the world
8.64K
5.94%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月31日 周六
更新时间: 1月31日 周六
持股股东
股东类型
持股股东
持股股东
占比
Ayrton Capital LLC
6.14%
The Vanguard Group, Inc.
3.14%
Orca Capital GmbH
3.10%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
其他
84.26%
持股股东
持股股东
占比
Ayrton Capital LLC
6.14%
The Vanguard Group, Inc.
3.14%
Orca Capital GmbH
3.10%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
其他
84.26%
股东类型
持股股东
占比
Investment Advisor
9.65%
Hedge Fund
7.58%
Individual Investor
5.87%
Investment Advisor/Hedge Fund
1.02%
Research Firm
0.44%
Bank and Trust
0.03%
其他
75.41%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
80
11.14M
13.43%
-308.03K
2025Q3
83
11.45M
12.86%
+6.26M
2025Q2
88
5.18M
18.12%
-695.54K
2025Q1
96
5.88M
20.77%
-1.09M
2024Q4
104
5.75M
18.48%
+1.31M
2024Q3
108
4.45M
20.26%
-229.17K
2024Q2
125
4.65M
21.94%
+232.83K
2024Q1
134
4.41M
23.86%
-3.05M
2023Q4
144
4.75M
24.82%
-54.54K
2023Q3
160
4.81M
26.97%
+93.65K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Ayrton Capital LLC
124.61K
6.14%
+124.61K
--
Sep 30, 2025
The Vanguard Group, Inc.
56.87K
2.8%
-910.00
-1.58%
Sep 30, 2025
Orca Capital GmbH
62.86K
3.1%
-10.27K
-14.04%
Oct 28, 2025
Private Advisory Group LLC
39.39K
1.94%
--
--
Sep 30, 2025
Renaissance Technologies LLC
28.92K
1.42%
+10.22K
+54.63%
Sep 30, 2025
Egan (Dwight H.)
28.73K
1.42%
+3.79K
+15.21%
Nov 23, 2025
Abbott (Richard David)
23.22K
1.14%
+1.32K
+6.01%
Nov 23, 2025
Brown (Brian Lee)
23.09K
1.14%
+3.12K
+15.59%
Nov 23, 2025
BlackRock Institutional Trust Company, N.A.
14.25K
0.7%
--
--
Sep 30, 2025
Serbin (Richard S)
10.97K
0.54%
+1.92K
+21.17%
Nov 23, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Jul 11, 2025
Merger
30→1
公告日期
除权除息日
类型
比率
Jul 11, 2025
Merger
30→1
KeyAI